Learn more about our Legal work.
AdvaMed® issued a statement regarding the decision from the New Jersey Appellate Division’s decision to remand the McGinnis case for a new trial preceded by Rule 104 hearing on the 510(k) clearance…
AdvaMed® advocates for responsible advertising for patient safety.
AdvaMed® advocates on a global basis for the highest ethical standards and works to facilitate a legal environment that fosters medical technology innovation and timely patient access to safe and effective…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from Pat Fogarty, Vice President, Assistant General Counsel, and Director, Civil Justice Policy regarding yesterday’s oral arguments…
This brochure provides an overview of the Physician Payments Sunshine Act.
Unequal access to medical technologies and, more broadly, health care services continues to persist – often disproportionately impacting the lives of racial and ethnic minorities.
AdvaMed® provided comments on the proposed rule regarding the HHS good guidance practices.